COLLAGENS
Acid soluble native type I collagen was extracted from fetal calf skin and purified by the method of Jackson and Cleary. 9 Native bovine type II collagen was extracted from nasal septa by pepsin digestion after prior treatment with 2 M magnesium chloride in 0-05 M TRIS-HCl, pH 7-4, to remove the proteoglycans, and purified further. 16 Native IX and XI collagens were extracted from fetal bovine articular cartilage by similar methods and extensively purified by differential salt precipitation and by dialysis against phosphate buffer.1520
The collagens were stored at -20°C until used. Acid soluble type I collagen was dissolved at 2 mg/ml in 0-1 M acetic acid and dialysed into 0-45 M sodium chloride/0-02 M TRIS buffer, pH 7-5, before use. The other collagens were dissolved directly in the sodium chloride/TRIS buffer at the same concentration. They were diluted in the same buffer to 10 .tg/ml for coating the plates in the anticollagen antibody assay (see below). To denature the collagens the solutions of collagens were heated in a water bath at 46°C for 20 minutes immediately before use.
ANTICOLLAGEN ANTIBODIES
Antibodies to specific collagens were measured in the sera by a solid phase, double antibody, enzyme labelled immunoassay. Linbro 96 well ELISA (enzyme linked immunosorbent assay) plates were coated overnight at 4°C with 200 pl/well of a 10 jig/ml solution of collagen in 0.45 M sodium chloride/0-02 M TRIS buffer, pH 7-5. The procedure was the same for both native and denatured collagens. Control plates were coated with 200 pl of 0-1% (w/v) bovine serum albumin in phosphate buffered saline containing 0-05% (w/v) Tween 20, pH 7-5 (BSA/PBS/Tween). After washing six times with phosphate buffered saline, pH 7-5, containing 0-05% (w/v) Tween 20 (PBSITween) the remaining binding sites in the wells were blocked with 300 pul of BSA/PBS/Tween for four hours at room temperature. After washing the plates six times with PBS/Tween the sera diluted 100 times in BSA/PBS/ Tween were added to the wells (200 RI) in duplicate.
The plates were left overnight at 4°C and then washed six times with PBS/Tween. The second antibody (200 pl/well), which was alkaline phosphatase labelled, was added at a dilution of 1:2000 
STATISTICS
Antibodies to different antigens were tested for correlation by the Spearman rank correlation coefficient test.
Results

ANTIBODIES TO NATIVE COLLAGENS
The mean absorbance value of the 90 donors was 22 Table 1 for the three groups. The levels of antibody to these other collagens are shown in Table 2 . Sera from patients with RA who had antibodies to native type II collagen had the highest incidence of antibodies to the other native collagens. collagens are exposed, and thus antibodies may be unrelated to the initiation of the arthritis but may have a role in its development and be markers of the extent of existing or potential cartilage damage. Alternatively, immunity to collagens or a foreign antigen with similar epitopes could produce antibodies which then could initiate the inflammatory processes in the joint. Recently, the ability of antibodies to type II collagen from a patient with RA to initiate an inflammatory arthritis in mice has been described.21
Whatever the role for these antibodies it probably is not a universal one in all patients with RA. Many patients showed no evidence of any antibodies to these collagens whether native or denatured. Also RA patients with antibodies to native type II collagen form a distinct genetic subset,22 though they could not be distinguished on clinical grounds from the other patients with RA. An individual patient with antibodies to native type II collagen or another collagen at one stage in their disease, however, may be negative for these antibodies at another stage (personal observations). Such changes could be due to fluctuations in disease activity or the treatment.
Although these studies give us a very good idea of the incidence of such antibodies in a RA population, they are but a snapshot in time. 
